Friday 6 November 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.

Revenue: +38.6%
EPS: +16.3%
Free cash flow: +21.8%
Total debt: +15.0%

Quarter to September 2026, against a year earlier

1,370.24 47.75 −3.37%

Follow LLY

Alert me

Market cap: $1.28T
P/E: 44.5×
Fwd P/E: 41.5×
Dividend yield: 0.49%
F-score: 7/9
Altman Z: 8.61
Beneish M: −1.91
Dividend safety: 86/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Eli Lilly and Company (LLY) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Eli Lilly and Company (LLY) trades at a P/E ratio of 44.5×. Over the past ten years it has ranged from 0.0× (September 2018) to 264× (November 2018); the current reading is higher than 64% of that period. That is above the Drug Manufacturers General industry median of 26.6× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/LLY/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Eli Lilly and Company P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/LLY/metrics/pe-ratio">Eli Lilly and Company (LLY) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	46.8×	(28.97%)
FY2024	65.9×	(35.43%)
FY2023	102×	93.02%
FY2022	52.9×	17.58%
FY2021	45.0×	81.18%
FY2020	24.8×	65.87%
FY2019	15.0×	(59.51%)
FY2018	37.0×	—
FY2017	0.0×	—
FY2016	28.9×	(22.45%)

Period	P/E ratio	Change
Sep 2026	37.6×	(6.69%)
Jun 2026	40.2×	23.18%
Mar 2026	32.7×	(30.22%)
Dec 2025	46.8×	25.44%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 264×

Ten-year median 39.2×

Current reading's percentile 59

Company	P/E ratio
GILD Gilead Sciences, Inc. compare	n/m
AZN AstraZeneca PLC compare	26.3×
AMGN Amgen Inc. compare	26.6×
NVS Novartis AG compare	30.9×
JNJ Johnson & Johnson compare	41.3×
PFE Pfizer Inc. compare	42.2×
LLY Eli Lilly and Company	44.5×
ABBV AbbVie Inc. compare	49.7×
MRK Merck & Co., Inc. compare	118×
Drug Manufacturers General industry median	26.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Eli Lilly and Company (LLY) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on LLY

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on LLY

Stockrow Weekly